Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Orchestra BioMed Holdings Inc’s stock clocked out at $2.72, down -0.37% from its previous closing price of $2.73. In other words, the price has decreased by -$0.37 from its previous closing price. On the day, 0.11 million shares were traded. OBIO stock price reached its highest trading level at $2.75 during the session, while it also had its lowest trading level at $2.605.
Ratios:
To gain a deeper understanding of OBIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.34 and its Current Ratio is at 3.35. In the meantime, Its Debt-to-Equity ratio is 0.98 whereas as Long-Term Debt/Eq ratio is at 0.94.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on March 20, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On January 02, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $16.
On August 22, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $14.H.C. Wainwright initiated its Buy rating on August 22, 2024, with a $14 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 30 ’25 when RTW INVESTMENTS, LP bought 49,900 shares for $2.99 per share. The transaction valued at 149,201 led to the insider holds 8,306,063 shares of the business.
RTW INVESTMENTS, LP bought 50,000 shares of OBIO for $126,500 on Apr 29 ’25. The 10% Owner now owns 8,256,163 shares after completing the transaction at $2.53 per share. On Dec 23 ’24, another insider, Hochman David P, who serves as the insider of the company, bought 4,000 shares for $4.66 each. As a result, the insider paid 18,640 and bolstered with 579,498 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OBIO now has a Market Capitalization of 104210000 and an Enterprise Value of 70770032. For the stock, the TTM Price-to-Sale (P/S) ratio is 36.06 while its Price-to-Book (P/B) ratio in mrq is 6.18. Its current Enterprise Value per Revenue stands at 24.522 whereas that against EBITDA is -1.033.
Stock Price History:
The Beta on a monthly basis for OBIO is 0.63, which has changed by -0.6097561 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, OBIO has reached a high of $8.87, while it has fallen to a 52-week low of $2.37. The 50-Day Moving Average of the stock is -14.48%, while the 200-Day Moving Average is calculated to be -43.79%.
Shares Statistics:
It appears that OBIO traded 361.86K shares on average per day over the past three months and 146490 shares per day over the past ten days. A total of 38.31M shares are outstanding, with a floating share count of 26.64M. Insiders hold about 30.47% of the company’s shares, while institutions hold 49.80% stake in the company. Shares short for OBIO as of 1745971200 were 1231552 with a Short Ratio of 3.40, compared to 1743379200 on 572290. Therefore, it implies a Short% of Shares Outstanding of 1231552 and a Short% of Float of 6.6000000000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
